![Saad Urrehman Gilani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Saad Urrehman Gilani
Head-Equity Investments chez
Yorkville Advisors LLC
Profil
Mr. Saad Urrehman Gilani is a Managing Director at Yorkville Advisors LLC.
He is on the Board of Directors at Temple Therapeutics BV.
He is a member of the firm’s Investment Committee.
He also sits on the supervisory boards of Cyxone AB based in Sweden and Temple Therapeutics BV based in the Netherlands.
He is only interested in Nasdaq/NYSE-listed companies.
Prior to joining Yorkville, Mr. Gilani worked at Keyence Corporation for over 11 years where he held various management roles within the Engineering and Marketing groups.
He earned a BS in Electrical Engineering and received his MBA from Rutgers Business School where he specialized in finance.
Postes actifs de Saad Urrehman Gilani
| Sociétés | Poste | Début |
|---|---|---|
Yorkville Advisors LLC
 Yorkville Advisors LLC Investment ManagersFinance Yorkville is a generalist investor with a focus on capital-intensive industries. Current active sectors include Healthcare, Metals and Mining, Energy, Technology, and Electric Vehicles. The firm invests their funds' capital through customized structured debt and equity investments. Their investment criteria focuses on management teams, business fundamentals, and stock trading metrics. Yorkville funds has broad investment mandates across many sectors and geographies. Their funds are often the sole investor in a capital raise, allowing for a controlled and disciplined exit strategy. | Head-Equity Investments | 01/01/2005 |
Temple Therapeutics BV
 Temple Therapeutics BV BiotechnologyHealth Technology Develops therapies for orthopedics, oncology and endometriosis patients | Directeur/Membre du Conseil | 01/07/2015 |
Anciens postes connus de Saad Urrehman Gilani
| Sociétés | Poste | Fin |
|---|---|---|
| KEYENCE CORPORATION | Corporate Officer/Principal | - |
| CYXONE AB | Directeur/Membre du Conseil | - |
Formation de Saad Urrehman Gilani
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
36
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
KEYENCE Corp.
 KEYENCE Corp. Electronic Equipment/InstrumentsElectronic Technology Manufactures and sells sensors and measuring instruments | Electronic Technology |
Yorkville Advisors LLC
Yorkville Advisors LLC Investment ManagersFinance Yorkville is a generalist investor with a focus on capital-intensive industries. Current active sectors include Healthcare, Metals and Mining, Energy, Technology, and Electric Vehicles. The firm invests their funds' capital through customized structured debt and equity investments. Their investment criteria focuses on management teams, business fundamentals, and stock trading metrics. Yorkville funds has broad investment mandates across many sectors and geographies. Their funds are often the sole investor in a capital raise, allowing for a controlled and disciplined exit strategy. | Finance |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers University School of Engineering
 Rutgers University School of Engineering Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cyxone AB
 Cyxone AB Pharmaceuticals: MajorHealth Technology Develops cyclotide drugs for autoimmune and other diseases | Health Technology |
Temple Therapeutics BV
Temple Therapeutics BV BiotechnologyHealth Technology Develops therapies for orthopedics, oncology and endometriosis patients | Health Technology |
